Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Network To Boost Coordination On Innovative Drugs Across Europe

Executive Summary

The newly established EU Innovation Network aims to increase the visibility of the support being offered by national competent authorities to innovative medicinal products in member states, and help boost the delivery of novel medicines to patients.

You may also be interested in...



Simultaneous Early Scientific Dialogue On The Cards In Europe For Innovators

Regulators involved in the EU Innovation Network are working on a pilot aimed at sponsors, who want to have an early dialogue on product development issues with a national competent authority in Europe, but also want to get other NCAs or innovation offices involved.

EMA's Rasi To Head Global Coalition Of Drug Regulators

European Medicines Agency chief Guido Rasi, will replace the UK's Ian Hudson as chair of the International Coalition of Medicines Regulatory Authorities in October.

EU Initiative Flags Up Challenging Products For Regulators

A new EU group is keeping a bird's eye view on new innovative medicinal products being brought before member states’ innovation offices, and has flagged up "emerging challenges" and "interesting cases" identified throughout 2017 that need further discussion at the level of the EU medicines network.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS119855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel